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INTRODUCTION
The estimated global incidence of cervical cancer
in 2008 was approximately 15%.1 Cervical cancer
does not only have a major impact on women’s
health, it is also still ranked the second leading
cause of cancer-related death in women world-
wide.1,2 The overall mortality rate was 60% in the
entire world.2 Approximately 86% of the global
Abstract
Objective: Persistence of high-risk HPV infection is known to be the
major cause of cervical cancer. It is important to differentiate the
genotype of HPV infection, whether it is high, intermediate or low
risk. The aim of this study was to assess the prevalence of high-risk
HPV types among Indonesian women with negative VIA.
Method: We analyzed cervical swabs from 1,214 patients with nega-
tive VIA. By using INNO-Lipa HPV DNA test, we detected the HPV
DNA and its genotype.
Result: From the 1,214 women with negative VIA, 48 (3.95%) sam-
ples were confirmed to have positive HPV DNA by using PCR and
electrophoresis. However, hybridization test were not able to detect
HPV genotypes in 9 samples. These 9 samples were tested again
with PCR and electrophoresis and resulted in negative HPV DNA.
Among the remaining 39 samples (3.21%), we detected 19 types of
HPV, consisting of 13 types of high-risk HPV, 5 types of low-risk HPV,
and 1 type of unknown HPV (type X).
Conclusion: Among patients with negative VIA, 3.21% was found to
be positive for HPV DNA. From this percentage, the prevalence of
high-risk HPV is higher than the low-risk and unknown HPV. There-
fore we cannot ignore results of negative VIA, particularly in high-
risk group, because there is a slight possibility that presence of HPV
can be identified, especially the high risk ones which have a ten-
dency to be persistent. We support the importance of HPV DNA test
as cervical cancer screening method.
[Indones J Obstet Gynecol 2014; 3: 153-156]
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Abstrak
Tujuan: Infeksi persisten HPV risiko tinggi merupakan penyebab
utama kanker serviks. Sangatlah penting untuk mengklasifikasikan
genotip dari infeksi HPV ke dalam kelompok tipe HPV risiko tinggi, me-
nengah atau rendah. Tujuan dari penelitian ini adalah untuk menge-
tahui prevalensi infeksi HPV tipe risiko tinggi pada perempuan Indo-
nesia dengan hasil pemeriksaan IVA negatif.
Metode: Dilakukan evaluasi terhadap 1214 sampel swab serviks dari
subjek dengan hasil pemeriksaan IVA negatif. Dengan menggunakan
tes DNA HPV INNO-Lipa, dilakukan pemeriksaan deteksi DNA HPV
dan genotipnya.
Hasil: Berdasarkan pemeriksaan PCR dan elektroforesis didapatkan 48
dari 1214 subjek (3,95%) memiliki hasil DNA HPV positif. Setelah di-
lakukan pemeriksaan hibridisasi, genotip HPV tidak dapat diidentifi-
kasi pada 9 dari 48 sampel. Dilakukan pemeriksaan PCR dan elektrofore-
sis kembali terhadap 9 sampel tersebut dan didapatkan hasil DNA HPV
negatif sehingga sampel yang memiliki hasil positif DNA HPV adalah 39
sampel (3,21%). Dari sampel tersebut ditemukan 19 tipe HPV yaitu, 13
tipe HPV risiko tinggi, 5 tipe HPV risiko rendah dan 1 tipe HPV yang tidak
diketahui klasifikasinya (tipe X).
Kesimpulan: Di antara subjek dengan IVA negatif, diidentifikasi DNA
HPV positif pada 3,21% kelompok sampel. Prevalensi tipe HPV risiko
tinggi lebih tinggi dibandingkan dengan HPV risiko rendah dan HPV
yang belum terklasifikasi. Berdasarkan temuan ini, hasil IVA yang ne-
gatif tidak dapat diabaikan begitu saja, terutama pada kelompok
risiko tinggi, karena mungkin saja sudah terinfeksi HPV tipe risiko
tinggi. Temuan ini mendukung pernyataan bahwa pemeriksaan DNA
HPV merupakan pemeriksaan skrining kanker serviks yang penting.
[Maj Obstet Ginekol Indones 2014; 3: 153-156]
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problem of cervical cancer occur in developing
countries accounting for 13% of all cancers in
women.2 In Indonesia, data from the Cancer Reg-
istration Board of Association of Indonesian Pa-
thologists show that cervical cancer ranks first of
the 10 most common cancers in women in the year
2006.
The major causative factor of cervical carcino-
genesis is a persistent infection of human papil-
lomavirus (HPV). The hypothesis of the presence
of a correlation between HPV infection and cervical
neoplasia was first put forward by Harold zur
Hausen, a German virologist.3 The relationship be-
tween HPV and cervical cancer is more significant
than the relationship between smoking and lung
cancer. More than 200 types of HPV have been
identified based on DNA sequence data, which are
grouped into high-risk HPV (HR-HPV), intermedi-
ate-risk HPV (IR-HPV), and low-risk HPV (LR-
HPV).4,5 Until now, there has been no study on the
prevalence of HPV in Indonesia in populations that
have been screened, especially involving a large
number of samples. Several studies which have
been conducted were carried out in the general
population, patients with pre-cancerous lesions
and cervical cancer.6-8 Vet et al reported the preva-
lence of HPV was 11.4% in the general population,
while study Boer et al reported a prevalence of
25.4%.8,9 The types of high-risk HPV commonly
found in the general population in Indonesia are
types 52, 16, 18, and 51, but the prevalence still
has a wide inter-study range.7-9 Type 52 is the most
common type found in the general population.8
Due to that reason, it is important to differentiate
the genotype of HPV infection, whether it is high,
intermediate or low risk. This study aims to assess
the prevalence of high-risk HPV types among Indo-
nesian women with negative VIA.
METHODS
This study was conducted at the Obstetrics and Gy-
necology Clinic of Dr. Cipto Mangunkusumo hospi-
tal, health centers, and other designated healthcare
facilities of the "See and Treat" Female Cancer Pro-
gramme (FCP) in Jakarta, as well as at the Depart-
ment of Gynecology and Department of Pathology,
Leiden Universiteir Medisch Centrum (LUMC), The
Netherlands. It was carried out from January 2012
to May 2013.
Subjects in this study were recruited in accord-
ance to inclusion and exclusion criteria. We in-
cluded married subjects aged 20-50 years who
agreed to participate in this study, resides perma-
nently in Jakarta and had negative VIA result. We
took samples from the subjects using vaginal swab.
By using INNO Lipa HPV DNA test, we detected the
HPV DNA and its genotype from the samples.
RESULTS
Subjects in this study had a low risk factor for HPV
infection as shown in Table 1. From 1,214 women
with negative VIA, 48 (3.95%) samples were con-
firmed to be positive for HPV DNA by using PCR
and electrophoresis. However, HPV genotypes we-
re not detected in 9 out of 48 samples by using
hybridization test. These nine samples were tested
again with PCR and electrophoresis resulting in
negative HPV DNA. Among the remaining 39 sam-
ples (3.21%), we detected 19 types of HPV consist-
ing of 13 types of high-risk HPV, 5 types of low-risk
HPV, and 1 type of unknown HPV (type X). HPV
DNA test results are shown in Table 2.
Table 1. Characteristic of Subject.
Variable Description
Age (years) 40.9   9.28
Age at first marriage (years) 22.0   4.31
Marital status subjects
 Married one time 1054 (88.2%)
 Married more than once 75 (6.3%)
 Widow 65 (5.5%)
Marital status couples
 Married one time 1060 (92.6%)
 Married more than once 84 (7.4%)
Parity 2.3   1.57
Smoking status
 Smoke 69 (5.7%)
 Do not smoke 1145 (94.3%)
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Table 2. HPV DNA Test Results.
Variable n %
HPV DNA (+) 39 3.21
HPV DNA (-) 1175 96.79
High-risk HPV 13 68.42
Non high-risk HPV 5 26.32
HPV-X 1 5.26
Nineteen types of HPV were detected, namely
HPV types 6, 16, 18, 31, 39, 44, 51, 52, 53, 54, 56,
58, 66, 68, 69, 71, 73, 74, and one unknown type
(HPV X). HPV type 52 was identified as the most
common type, with a proportion of 13/71
(18.31%). The next most common types of HPV are
types 39 and X (9.86%); types 16,18, and 74
(8.45%); and types 44, 54, and 66 (4.22%). The
proportions of HPV types detected in negative VIA
patients are presented in Table 3.
Table 3. HPV Types Detected in VIA Negative Patients.
No. HPV Type n (71) %(100)
1. HPV 6 1 1.41
2. HPV 16 6 8.45
3. HPV 18 6 8.45
4. HPV 31 1 1.41
5. HPV 39 7 9.86
6. HPV 44 3 4.22
7. HPV 51 2 1.41
8. HPV 52 13 18.31
9. HPV 53 1 1.41
10. HPV 54 3 4.22
11. HPV 56 2 1.41
12. HPV 58 2 1.41
13. HPV 66 3 4.22
14. HPV 68 2 1.41
15. HPV 69 2 1.41
16. HPV 71 2 1.41
17. HPV 73 2 1.41
18. HPV 74 6 8.45
19. HPV X 7 9.86
DISCUSSION
This study showed a higher prevalence of HR-HPV
compared to non HR-HPV infection in the positive
HPV DNA group. Nineteen types of HPV were de-
tected, consisting of 13 types of HR-HPV (type 16,
18, 31, 39, 51, 52, 56, 58, 66, 68, 69, 71, and 73), 5
types of non-HR-HPV (type 6, 44, 53, 54, and 74),
and 1 type of unknown HPV classification (HPV X).
The prevalence of HR-HPV infection in this study
is higher than that reported by Carcopino, et al,10
which is 21.9%. Our study found that among sub-
jects with negative VIA, HR-HPV infection was more
commonly detected than non HR-HPV infection in
the positive HPV DNA group. This fact implies that
although the prevalence of HPV infection in subjects
with negative VIA is relatively very low (3.21%), the
majority of subjects (68.42%) had HR-HPV infec-
tion.
The more commonly identified HR-HPV plays a
significant role in the natural history of cervical can-
cer. Persistence of HR-HPV is known to be the ma-
jor cause of cervical cancer. Hopman et al conducted
a study in a population with normal cytology.11 It
appears that the persistence of HR-HPV infection
was significantly related to the development of ab-
normal cytology.
More than 13 HPV genotypes were grouped into
high-risk types, which can infect epithelial cells of
the basal layer of the skin or mucosal tissue.12,13
These HPV types may infect the epidermal tissue of
hand and foot, and the epithelium of mouth, throat,
respiratory tract, or anogenital mucosal lining.4
Mucosal HPVs are further classified based on their
ability to cause precursor lesions and cervical can-
cer. HR-HPV, especially type 16, 18, 45, and 56, are
particularly associated with the development of cer-
vical cancer.13 Type 16 and 18 mucosal HR-HPV are
the most frequently detected HPV types in female
anogenital system, and are present in >90% cervical
cancer cases, and >50% of other anogenital invasive
carcinoma.13,14
Intermediate-risk HPV (IR-HPV) are another
group of HPV types which are more rarely found in
cancers, but are often found in squamous intra-epi-
thelial lesions (SIL). Low Risk-HPV (LR-HPV) type
includes type 6, 11, 42, 43, and 44.4
CONCLUSION
Among the negative VIA, there was 3.21% positive
HPV DNA. From this percentage, the prevalence of
Vol 2, No 3
July 2014 Prevalence of high risk human papillomavirus  155
high-risk HPV is higher than the low-risk and un-
known HPV. Therefore we cannot ignore results of
negative VIA, particularly in high-risk group, be-
cause there is a slight possibility that presence of
HPV can be identified, especially the high risk ones
which have a tendency to be persistent. We sup-
port the importance of HPV DNA test as cervical
cancer screening method.
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